Literature DB >> 35026696

Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.

Annie Garcia1, Lauren Desrosiers2, Sarah Scollon2, Stephanie Gruner2, Jacquelyn Reuther1, Ilavarasi Gandhi1, Ninad Patil1, Maren Y Fuller1, Hongzheng Dai3, Donna Muzny4, Richard A Gibbs5, Jennifer L Bercaw-Pratt6, Seema L Rao2, Nino Rainusso7, Kevin E Fisher8, Frank Y Lin7, Sharon E Plon9, D Williams Parsons10, Angshumoy Roy11.   

Abstract

Entities:  

Keywords:  DICER1; Mosaic; Pathogenic; RNase IIIb; Sertoli-Leydig

Mesh:

Substances:

Year:  2022        PMID: 35026696      PMCID: PMC8920771          DOI: 10.1016/j.cancergen.2022.01.001

Source DB:  PubMed          Journal:  Cancer Genet


× No keyword cloud information.
  7 in total

1.  DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.

Authors:  Kris Ann P Schultz; Anne K Harris; Michael Finch; Louis P Dehner; Jubilee B Brown; David M Gershenson; Robert H Young; Amanda Field; Weiying Yu; Joyce Turner; Nicholas G Cost; Dominik T Schneider; Douglas R Stewart; A Lindsay Frazier; Yoav Messinger; D Ashley Hill
Journal:  Gynecol Oncol       Date:  2017-10-14       Impact factor: 5.482

2.  Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.

Authors:  Alireza Heravi-Moussavi; Michael S Anglesio; S-W Grace Cheng; Janine Senz; Winnie Yang; Leah Prentice; Anthony P Fejes; Christine Chow; Alicia Tone; Steve E Kalloger; Nancy Hamel; Andrew Roth; Gavin Ha; Adrian N C Wan; Sarah Maines-Bandiera; Clara Salamanca; Barbara Pasini; Blaise A Clarke; Anna F Lee; Cheng-Han Lee; Chengquan Zhao; Robert H Young; Samuel A Aparicio; Poul H B Sorensen; Michelle M M Woo; Niki Boyd; Steven J M Jones; Martin Hirst; Marco A Marra; Blake Gilks; Sohrab P Shah; William D Foulkes; Gregg B Morin; David G Huntsman
Journal:  N Engl J Med       Date:  2011-12-21       Impact factor: 91.245

3.  DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.

Authors:  Leanne de Kock; Tatjana Terzic; W Glenn McCluggage; Colin J R Stewart; Patricia Shaw; William D Foulkes; Blaise A Clarke
Journal:  Am J Surg Pathol       Date:  2017-09       Impact factor: 6.394

4.  Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms.

Authors:  W Glenn McCluggage; Anne-Laure Chong; Leanne de Kock; William D Foulkes
Journal:  Histopathology       Date:  2020-06-12       Impact factor: 5.087

5.  Results from a Monocentric Long-Term Analysis of 23 Patients with Ovarian Sertoli-Leydig Cell Tumors.

Authors:  Sebastien Gouy; Alexandra Arfi; Amandine Maulard; Patricia Pautier; Enrica Bentivegna; Alexandra Leary; Cyrus Chargari; Catherine Genestie; Philippe Morice
Journal:  Oncologist       Date:  2018-09-10

Review 6.  Spectrum of DICER1 Germline Pathogenic Variants in Ovarian Sertoli-Leydig Cell Tumor.

Authors:  Elisa De Paolis; Rosa Maria Paragliola; Paola Concolino
Journal:  J Clin Med       Date:  2021-04-23       Impact factor: 4.241

7.  Distinct DICER1 Hotspot Mutations Identify Bilateral Tumors as Separate Events.

Authors:  Kenneth S Chen; Sarai H Stuart; Emily K Stroup; Abhay S Shukla; Jason Wang; Veena Rajaram; Gordan M Vujanic; Tamra Slone; Dinesh Rakheja; James F Amatruda
Journal:  JCO Precis Oncol       Date:  2018-04-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.